A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf.
Covid-19: Molnupiravir reduces risk of hospital admission or death by 50% in patients at risk, MSD reports
2021
The BMJ (British Medical Journal)
Preserved Fulltext
The antiviral drug molnupiravir reduced the risk of admission to hospital or death by around 50% in non-hospitalised adults who had mild to moderate covid-19 and were at risk of poor outcomes, Merck Sharp and Dohme (MSD) has reported. 1 NEWS The BMJ
doi:10.1136/bmj.n2422
pmid:34607801
fatcat:pmkh4a3xqfh6dnil23yyzqaalq